Watson for Genomics analyzes patients’ genomic, clinical and pharmacological data to identify personalized treatment options, such as genetic alterations, drugs and clinical trials.
“Despite the promise of precision medicine, data-driven challenges make it difficult for oncologists to bring genomic advances to their patients,” said Gang Fu, chair of Baheal. “We believe Watson will help accelerate this growing field so that research advances can be accessed for patient benefit more quickly.”
The Watson for Genomics agreement arrives less than three months after IBM and Baheal launched a strategic partnership to distribute Watson for Oncology in China. Baheal has since implemented Watson for Oncology at eight hospitals.
More articles on health IT:
Dr. Sean Tunis elected president of HTAi
ONC updates certified health IT product landing page
HHS CIO estimates 500M hack attempts per week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.